Literature DB >> 30816366

Advanced Clinical Stage at Diagnosis of Breast Cancer Is Associated with Poorer Health-Related Quality of Life: A Cross-Sectional Study.

Julia de Mello Ramirez Medina1, Ingrid de Araujo Trugilho1, Giovanna Nunes Belo Mendes2, Josiel Guedes Silva3, Maria Alexsandra da Silva Paiva4, Suzana Sales de Aguiar1, Luiz Claudio Santos Thuler1, Anke Bergmann1.   

Abstract

OBJECTIVE: To describe the clinical stage in women diagnosed with breast cancer and the association between clinical stage and Health-related quality of life (HRQoL).
MATERIALS AND METHODS: This was a cross-sectional study involving women diagnosed with breast cancer. HRQoL was assessed with European Organization for Research and Treatment of Cancer 30-Item Quality of Life Questionnaire and the Quality of Life Questionnaire Breast Cancer 23. The principal exposure was clinical stage (<IIB versus ≥IIB). Simple linear regression was performed and variables with p<0.20 were selected for the multiple linear regression. The final model was composed of statistically significant variables (p<0.05).
RESULTS: In total, 302 women were included. The majority (58.9%) had been diagnosed with advanced stage cancer (≥IIB). Those at an advanced clinical stage had poorer role functioning (p=0.029), pain (p<0.001), and symptoms in the breast (p<0.001).
CONCLUSION: Advanced clinical stage at diagnosis was found to be associated with worse health-related quality of life in breast cancer patients.

Entities:  

Keywords:  Breast neoplasm; neoplasm staging; quality of life

Year:  2018        PMID: 30816366      PMCID: PMC6385723          DOI: 10.5152/ejbh.2018.4297

Source DB:  PubMed          Journal:  Eur J Breast Health


  16 in total

Review 1.  The epidemiology of cancer pain.

Authors:  Leonidas C Goudas; Rina Bloch; Maria Gialeli-Goudas; Joseph Lau; Daniel B Carr
Journal:  Cancer Invest       Date:  2005       Impact factor: 2.176

2.  Stage, treatment and outcomes for patients with breast cancer in British Columbia in 2002: a population-based cohort study.

Authors:  Ashley Davidson; Stephen Chia; Robert Olson; Alan Nichol; Caroline Speers; Andy J Coldman; Chris Bajdik; Ryan Woods; Scott Tyldesley
Journal:  CMAJ Open       Date:  2013-11-07

3.  Determinants of advanced stage presentation of breast cancer in 87,969 Brazilian women.

Authors:  Karen de Souza Abrahão; Anke Bergmann; Suzana Sales de Aguiar; Luiz Claudio Santos Thuler
Journal:  Maturitas       Date:  2015-08-29       Impact factor: 4.342

4.  Insomnia in patients with advanced cancer.

Authors:  Mellar P Davis; Dilara Khoshknabi; Declan Walsh; Ruth Lagman; Alexandra Platt
Journal:  Am J Hosp Palliat Care       Date:  2013-04-23       Impact factor: 2.500

5.  [Factors leading to delay in obtaining definitive diagnosis of suspicious lesions for breast cancer in a dedicated health unit in Rio de Janeiro].

Authors:  Magda Côrtes Rodrigues Rezende; Hilton Augusto Koch; Juliana de Almeida Figueiredo; Luiz Claudio Santos Thuler
Journal:  Rev Bras Ginecol Obstet       Date:  2009-02

6.  Quality of life as a predictor of overall survival after breast cancer treatment.

Authors:  Suzana Sales De Aguiar; Anke Bergmann; Inês Echenique Mattos
Journal:  Qual Life Res       Date:  2013-07-20       Impact factor: 4.147

7.  Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer.

Authors:  Fernanda Alessandra Silva Michels; Maria do Rosario Dias de Oliveira Latorre; Maria do Socorro Maciel
Journal:  Rev Bras Epidemiol       Date:  2013-06

8.  Quality of Life among Breast Cancer Patients In Malaysia.

Authors:  Sri Ganesh; Munn-Sann Lye; Fen Nee Lau
Journal:  Asian Pac J Cancer Prev       Date:  2016

9.  A revision of the quality of life-breast cancer survivors (QOL-BCS) instrument.

Authors:  Andres Azuero; Xiaogang Su; Patrick McNees; Karen Meneses
Journal:  Res Nurs Health       Date:  2013-03-19       Impact factor: 2.228

10.  Assessment of Quality of Life of Women with Breast Cancer.

Authors:  Zivana Gavric; Zivana Vukovic-Kostic
Journal:  Glob J Health Sci       Date:  2016-09-01
View more
  7 in total

1.  Machine learning-based random forest for predicting decreased quality of life in thyroid cancer patients after thyroidectomy.

Authors:  Yong Hong Liu; Jian Jin; Yun Jiang Liu
Journal:  Support Care Cancer       Date:  2021-11-16       Impact factor: 3.603

2.  Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7).

Authors:  Nadia Harbeck; Fabio Franke; Rafael Villanueva-Vazquez; Yen-Shen Lu; Debu Tripathy; Louis Chow; Govind K Babu; Young-Hyuck Im; David Chandiwana; Anil Gaur; Brad Lanoue; Karen Rodriguez-Lorenc; Aditya Bardia
Journal:  Ther Adv Med Oncol       Date:  2020-07-26       Impact factor: 8.168

3.  Monitoring TNM stage of female breast cancer and survival across the South Australian population, with national and international TNM benchmarking: A population-based cohort study.

Authors:  Ming Li; David Roder; Katina D'Onise; David Walters; Gelareh Farshid; Elizabeth Buckley; Chris Karapetis; Rohit Joshi; Timothy Price; Amanda Townsend; Caroline Louise Miller; David Currow; Kate Powell; Dianne Buranyi-Trevarton; Ian Olver
Journal:  BMJ Open       Date:  2020-06-28       Impact factor: 2.692

4.  Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells.

Authors:  Yu-Shih Lin; Yi-Chia Shen; Ching-Yuan Wu; Ying-Ying Tsai; Yao-Hsu Yang; Yin-Yin Lin; Feng-Che Kuan; Cheng-Nan Lu; Geng-He Chang; Ming-Shao Tsai; Cheng-Ming Hsu; Reming-Albert Yeh; Pei-Rung Yang; I-Yun Lee; Li-Hsin Shu; Yu-Ching Cheng; Hung-Te Liu; Yu-Huei Wu; Yu-Heng Wu; De-Ching Chang
Journal:  Front Pharmacol       Date:  2019-10-31       Impact factor: 5.810

5.  Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study.

Authors:  Peter A Fasching; J Thaddeus Beck; Arlene Chan; Michele De Laurentiis; Francisco J Esteva; Guy Jerusalem; Patrick Neven; Xavier Pivot; Giulia V Bianchi; Miguel Martin; David Chandiwana; Brad Lanoue; Antonia Ridolfi; Yingbo Wang; Karen Rodriguez Lorenc; Arnd Nusch
Journal:  Breast       Date:  2020-09-23       Impact factor: 4.380

6.  Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2- advanced breast cancer.

Authors:  Debu Tripathy; Tristan Curteis; Sara Hurvitz; Denise Yardley; Fabio Franke; K Govind Babu; Paul Wheatley-Price; Young-Hyuck Im; Radost Pencheva; Lucy A Eddowes; Pierre-Alexandre Dionne; David Chandiwana; Purnima Pathak; Brad Lanoue; Nadia Harbeck
Journal:  Ther Adv Med Oncol       Date:  2022-02-28       Impact factor: 8.168

7.  Frailty and its association with health-related quality of life among older cancer patients: an evidence-based study from China.

Authors:  Mingzhu Su; Nengliang Yao; Meimei Shang; Yuzhen Shen; Tingting Qin; Jialin Wang; Xiaojie Sun
Journal:  Health Qual Life Outcomes       Date:  2022-08-19       Impact factor: 3.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.